How to make regenerative medicine happen
Cell therapies hold the promise of more effective treatments for a range of diseases, but they face a long and expensive route to market. The key is to reduce risk and attract investors, says Keith Thompson, head of the UK Cell Therapy Catapult
Back small companies to deliver new medicines
Pharmaceutical R&D functions at its best in small, agile and innovative SMEs. Replacing state subsidies and grant funding for research with start-up and development capital, would bring productivity improvements, says Mark Bloomfield, CEO of French biotech Polyplus Transfection
ETH is dancing with Google Tango
Google is working with various universities and other institutions on Project Tango, an initiative to develop mobile devices that can detect surroundings in three dimensions and enable navigation indoors. The first devices are expected to hit the market next year. ETH Zurich has a significant role in the project.
Science|Business Innovation Board AISBL Annual Report 2012-2013
Could it help European universities innovate?
Perceptions of ACES finalists about the process of science entrepreneurship